Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for Hims & Hers Health, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kare Schultz: trading record in brief
Kare Schultz (chief executive) discloses dealings in 3 companies, chiefly Teva Pharmaceutical Industries Ltd, Hims & Hers Health, Inc. and International Flavors & Fragrances Inc. In total, 10 filings cover trades dated from 6 May 2021 to 14 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 18 August 2026: an option exercise, in Hims & Hers Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kare Schultz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
6,623 sharesClass A Common StockSEC:0001773751-26-000214:0
6,623 sharesClass A Common StockSEC:0001773751-25-000299:0
9,118 sharesClass A Common StockSEC:0001773751-25-000201:0
116,389 sharesOrdinary SharesSEC:0001209191-22-055177:0
1,089 shares0Common StockSEC:0001225208-22-006660:0
59,701 sharesOrdinary SharesSEC:0001209191-22-017058:0
65,047 sharesOrdinary SharesSEC:0001209191-22-014473:0
26,867 sharesOrdinary SharesSEC:0001209191-22-008417:0
180,000 sharesOrdinary SharesSEC:0001209191-21-062591:0
255 shares0Common StockSEC:0001225208-21-007798:0
10 of 10 declarations
